Popular Articles
Benefits Of Grapefruit

Additional Phase II Data Demonstrate Improvement In Reported Symptoms In Patients Who Still Experience GERD Symptoms Despite PPI Therapy
Adding AZD3355, a novel GABAB receptor agonist, to a proton pump inhibitor (PPI) in patients with Gastroesophageal Reflux Disease (GERD), resulted in a 35% reduction in the mean total number of reflux episodes 0-24 hours after dose, compared with placebo.[i] These data were presented at the Digestive Diseases Week annual meeting (DDW®, 30 May - 4 June, Chicago).
generic viagra online
C-Section Births Cause Genetic Changes That May Increase Odds For Developing Diseases In Later Life
Swedish researchers have discovered that babies born by Caesarean section
News of the day
Particles Held For On-Chip Analysis By Integrated Optical Trap
A new type of optical particle trap can be used to manipulate bacteria, viruses and other particles on a chip as part of an integrated optofluidic platform. The optical trap is the latest innovation from researchers at the Jack Baskin School of Engineering at the University of California, Santa Cruz, who are developing new sensor technology for biomedical analysis and other applications.
Oncology

Increased Vascular Endothelial Growth Factor Expression In Patients With Bladder Pain Syndrome/Interstitial Cystitis

UroToday.com - Angiogenesis is thought to be important in many chronic inflammatory disorders, including diabetic retinopathy, atherosclerosis, and inflammatory bowel disease. It has also been suggested that the angiogenic components of these diseases contribute to and exacerbate disease conditions. Increased levels of vascular endothelial growth factor (VEGF) have been detected in patients with asthma and have been shown to be correlated with the severity of the disease. Anti-VEGF therapy has been shown to ameliorate inflammation in animal models of chronic inflammatory bowel disease. This background forms the prelude to a very interested study by Kiuchi and colleagues from Osaka, Japan. The authors note that VEGF is a crucial angiogenic factor, and its secretion is strictly regulated to form functional vessel networks. Pericytes are perivascular cells that wrap around microvessels and contact endothelial cells through discontinuities in the shared basement membrane. When vessels lose pericytes, they become tortuous and hemorrhagic. Abnormal activity of VEGF contributes to insufficient coverage of pericytes, resulting in leaky and hemorrhagic vessels. Kiuchi and coworkers examined biopsy specimens from 30 patients with BPS/IC who demonstrated glomerulations on hydrodistention, and compared them with biopsies from 10 control patients who had isolated bladder tumors and no symptoms of voiding dysfunction. None of the control patients had glomerulations after distention. Immunohistochemical analysis for VEGF expression, microvessel density and immature microvessels was performed. Pericyte coverage of microvessels in the specimens was used as an indicator of mature microvessels, and pericytes were identified by double-immunohistochemistry for CD34 and í±-smooth muscle actin. The researchers generated data that allowed them to conclude that there is an increased VEGF and immature vascularization in the bladder biopsies from patients with BPS/IC, and VEGF expression was associated with the degree of pain experienced by the patients. Taken together, Kiuchi believes that VEGF might contribute to pain and promote the formation of immature vessels in the bladder of patients with BPS/IC. This increased immature vascularization might have a potential role in glomerulations in these patients. Kiuchi H, Tsujimura A, Takao T, Yamamoto K, Nakayama J, Miyagawa Y, Nonomura N, Takeyama M, Okuyama A BJU Int. 2009 Mar 4. (Epub ahead of print) doi:10.1111/j.1464-410X.2009.08467.x Written by UroToday.com Contributing Editor Philip M. Hanno, MD, MPH UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com Copyright © 2009 - UroToday


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):